Automation in Contemporary Clinical Information Systems: a Survey of AI in Healthcare Settings

Summary

Aims and objectives: To examine the nature and use of automation in contemporary clinical information systems by reviewing studies reporting the implementation and evaluation of artificial intelligence (AI) technologies in healthcare settings.

Method: PubMed/MEDLINE, Web of Science, EMBASE, the tables of contents of major informatics journals, and the bibliographies of articles were searched for studies reporting evaluation of AI in clinical settings from January 2021 to December 2022. We documented the clinical application areas and tasks supported, and the level of system autonomy. Reported effects on user experience, decision-making, care delivery and outcomes were summarised.

Results: AI technologies are being applied in a wide variety of clinical areas. Most contemporary systems utilise deep learning, use routinely collected data, support diagnosis and triage, are assistive (requiring users to confirm or approve AI provided information or decisions), and are used by doctors in acute care settings in high-income nations. AI systems are integrated and used within existing clinical information systems including electronic medical records. There is limited support for One Health goals. Evaluation is largely based on quantitative methods measuring effects on decision-making.

Conclusion: AI systems are being implemented and evaluated in many clinical areas. There remain many opportunities to understand patterns of routine use and evaluate effects on decision-making, care delivery and patient outcomes using mixed-methods. Support for One Health including integrating data about environmental factors and social determinants needs further exploration.

Keywords

Clinical information systems - artificial intelligence - automation - implementation - evaluation

1 Introduction

Artificial intelligence (AI) technologies are used for a range of tasks requiring pattern recognition, reasoning or learning [[1]]. While AI has been studied for more than 50 years, its current resurgence is largely driven by developments in machine learning (ML) and specifically deep learning (DL). Recently, these DL methods have achieved unprecedented levels of performance in a variety of tasks such as language and image generation, using generative AI methods, including generative pretrained transformers (GPTs). In healthcare, AI promises to transform care delivery as it has the potential to harness the vast amounts of genomic, biomarker, and phenotype data that are being generated across the health system and beyond [[2], [3]].

Indeed, AI technologies should play a central role in reaching the goals of One Health which seeks to balance and optimise the health of people, animals and the environment through surveillance, prevention, and mitigation at local, regional, national, and global levels [[4], [5]]. Adopting a One Health approach at the local level, for instance, can improve understanding of the dynamics of humans, animals, and the built-environment to inform infection control and prevention programs [[6]]. Another example is the integration of human as well as environmental surveillance and response systems to assist health systems in responding to and mitigating the effects of climate change [[7]].

Today, AI is incorporated into a variety of clinical systems for detecting findings, suggesting diagnoses and recommending treatments in data-intensive specialties like radiology, pathology and ophthalmology [[3]]. These AIs can aid human decision making – from systems that acquire and analyse data, provide options for decisions, to systems with the capability of making decisions entirely on their own [[1]]. With time, systems are expected to become increasingly autonomous, going beyond making recommendations to autonomously performing tasks such as controlling closed loop clinical machines like ventilators or insulin pumps, triaging patients or screening referrals [[8], [9]]. With the public release of generative AI, their applications in assisting clinicians to create health records and generate summaries of clinical evidence are rapidly emerging [[10]].

To be successful in healthcare, AI must perform well in real-world clinical settings. Yet there are many complex challenges in the “last mile” of implementation that may make technically high performing algorithms perform poorly in real-world settings [[11]]. A fundamental challenge here is that algorithms built using ML may not necessarily generalise well beyond the data upon which they are trained, making them potentially unsafe when used on different populations. Even for restricted tasks like image interpretation, AI can make erroneous diagnoses because of differences in the training and real-world populations, as well as differences in image capture workflows [[12]]. Such algorithmic risks may be exacerbated with generative AI, which can produce content that is incorrect, unsafe and not grounded in scientific evidence [[10]]. Another last mile challenge relates to how well an AI system is embedded within the local sociotechnical context of implementation, where an organization can be viewed as a network of people, processes, and technologies [[11]]. AI systems need to be seamlessly integrated into clinical workflows and existing clinical information systems (CISs) such as electronic health records (EHRs) and laboratory information systems (LISs). The performance and safety of these algorithms is highly reliant on the quality of data provided by CISs [[13]].

The aim of this survey is to examine automation in contemporary CISs to identify the range and impact of AI use. We review studies reporting AI implementation and evaluation in clinical settings to examine progress in digitalization and realising the potential of AI to support clinicians in delivering patient care. Given the volume and rapidly evolving nature of the literature, we do not attempt to be comprehensive. Rather, we highlight clinical application areas and autonomy in current AI to discuss opportunities and future directions for implementing and evaluating AI in real-world settings. In keeping with the focus of this Yearbook, we sought to identify exemplars of AI systems that integrated clinical data with environmental or social factors to improve care delivery.

2 Methods

2.1 Search Strategy and Study Selection

We reviewed studies about ML systems in clinical settings published between January 2021 and December 2022. PubMed/MEDLINE, Scopus, Web of Science and EMBASE databases were searched by combining the search terms “artificial intelligence”, “machine learning”, “deep learning”, “natural language processing” with “implement*”, “evaluat*” and “clinical”. In addition, we hand-searched the table of contents of major health informatics journals including the Journal of the American Medical Informatics Association (JAMIA), JAMIA Open, Applied Clinical Informatics (ACI), Journal of Medical Internet Research (JMIR), the International Journal of Medical Informatics (IJMI), BMJ Health and Care Informatics, NPJ Digital Medicine, and BMC Medical Informatics and Decision Making. Studies about the development and validation of ML models on historical data sets were excluded. The search was limited to English language articles and grey literature was excluded.

2.2 Data Extraction, Summarising and Reporting Findings

For each included study, we extracted information about the authors, year of publication, clinical area, setting, CIS integration, study design and the effects of AI interventions. Study areas were classified by the country in which they were conducted, using the United Nations' definition [[14]]. Exemplars of AI systems that integrated clinical data with social determinants or environmental factors including animal health were identified. Sociotechnical and ethical considerations for the use of AI in clinical settings were similarly identified. In addition, information about the clinical task and AI system tasks was extracted and used to examine the level of AI autonomy.

Clinical task. Clinical tasks supported by AI were categorised into [[15]]:

• a) Diagnosis: assisting with the detection, identification or assessment of disease, or risk factors;

• b) Triage: assisted with prioritising cases for clinician review, by flagging or notifying cases with suspected positive findings of time-sensitive conditions, such as stroke;

• c) Procedure: assisted users performing diagnostic or interventional procedures;

• d) Treatment: provided recommendations for therapy;

• e) Monitoring: assisting clinicians to monitor patient trajectory over time.

Level of autonomy. The level of autonomy was examined using a previously published three-level classification based on how clinical tasks are divided between the clinician and AI [[15]]:

1. Autonomous information: In these systems, there is a separation between AI and clinician contributions to a task, with the AI contributing information that clinicians can then use to make a decision, e.g., an imaging system that provides a coloured imaging display to help a clinician differentiate human tissues.

2. Assistive: These AIs overlap in capability with clinicians, but clinicians provide the final decision. For example, clinicians confirm or approve AI provided information or decisions, e.g., a system assists clinicians to detect osteoarthritis from a knee X-ray image with a disclaimer that the system should not be used without a full patient evaluation.

3. Autonomous decision: Here, the AI makes the decision for a clinical task, which can then be enacted by clinicians or the AI, e.g., a system screens retinal images for diabetic retinopathy in primary care with the result used to make patient referral decisions.

To determine the level of autonomy, we examined the AI task, the stage of human information processing automated by the AI [[9]], and the system inputs and outputs. The clinical use case was examined to assess whether clinicians needed to verify decisions provided by the AI (assistive) or could rely on the AI information or decisions (autonomous). Classification of the stage of human information processing and level of autonomy was performed by FM and reviewed by DL.

Reported effects of AI interventions were categorised (into user experience, decision-making, care delivery and patient outcomes) based on an established framework called the information value chain [[16]], which separates the multiple steps from system use to impacting clinical outcomes - interacting with AI, receiving new information, decision-making, care delivery. A narrative synthesis then integrated findings into descriptive summaries.

3 Results

We identified 62 studies examining AI systems in clinical settings in 19 countries (Appendix). Most were conducted in hospitals ([Figure 1]; [Table 1]; 73%, n=45) in high- and upper middle-income nations, specifically the United States (US) ([Figure 1]; n=22) and China (n=12). Studies largely used quantitative designs (74%, n=46) to evaluate the effects of AI in clinical settings and were predominantly focussed on assessing effects on decision-making (66%, n=41); only four were randomised controlled trials (RCTs). While none of the studies explicitly addressed the goals of One Health, consideration of the United Nations Sustainable Development Goals as well as social determinants and environmental factors such as the socioeconomic status and traffic volume was evident in a few studies [[17], [18]]. Aside from research ethics, none of the studies reported measures to consider or address ethical issues (e.g., algorithmic fairness) around the use of AI in clinical settings.

Fig. 1 Geographic distribution of AI studies reviewed in this survey (n=62).

Table 1 Characteristics of the 62 studies about AI systems in clinical settings included in this survey.

Most studies were focussed on AI for diagnostic (n=37) and triage tasks (n=10). Treatment, procedures and monitoring were less common. ML algorithms were commonly employed to assist in analysing clinical information (information analysis; n=15) and in selecting decisions (decision selection; n=39). Most systems were assistive (65%), requiring users to confirm or approve AI provided information or decisions covering 24 clinical areas. Integration with CISs including EHRs and LISs was described in some studies (n=22). In the following sections, we provide a summary of these studies by clinical area and summarise effects on decision-making, care delivery and patient outcomes.

3.1 Cancer

Nine studies focussed on AI for diagnosis and monitoring of different cancers. Wu et al. [[19]] conducted an RCT to demonstrate the effectiveness of real-time assistance for detection of early gastric cancer involving 1,050 patients at five hospitals in China. Compared with control, fewer lesions were missed in the AI group (mean 5 vs. 10). The AI correctly predicted early and advanced gastric cancers (accuracy: 85%, sensitivity: 100%, and specificity: 84%).

Another Chinese study examined effects on decision-making and care delivery. Peng et al. [[20]] conducted a prospective cohort study to demonstrate the efficacy of AI for detecting malignant thyroid nodules. Use of AI by 12 radiologists to interpret 366 ultrasound images and videos was shown to improve accuracy compared to unassisted interpretation (AUROC: 0.837 to 0.875), and projected to reduce the number of fine needle aspirations (62% to 35%) and decrease missed malignancy (19% to 17%).

Using mixed-methods, Calisto et al. [[21]] assessed the use and usability of a breast screening AI via a clinical simulation study; 45 radiologists completed three randomly selected cases from a set of 289. The study was informed by human-AI design guidelines and specifically examined the impact on clinical workflow as well as understanding, trust and acceptance of the AI. It found use of the system decreased false positives by 27% and false negatives by 4% while decreasing the time-to-diagnose by 3 min per patient; 91% of participants were satisfied with the AI.

The remaining six studies focussed on decision-making. Martins Jarnalo et al. [[22]] evaluated a commercial system for detecting pulmonary nodules in computed tomography (CT) images. When integrated into the clinical workflow of a Dutch radiology department, performance matched the vendor specification; (sensitivity: 88%, false-positive rate: 1.04 per scan and NPV: 95%). Quan et al. [[23]] assessed use of AI during colonoscopy. Their study, involving 300 patients found that AI assistance increased detection of adenomas and serrated polyps during colonoscopy in comparison to historical controls, but the findings were not statistically significant. Ou et al. [[24]] demonstrated that AI-assisted analysis of urine cytology outperformed the conventional method, with improved sensitivity (92% vs. 87%) and NPV (97% vs. 95%). Nasir-Moin et al. [[25]] showed that AI for interpretation of 100 colorectal polyp samples significantly improved pathologists' classification accuracy compared with standard microscopic assessment (74% to 81%). Duan et al. [[26]] demonstrated improved image quality, reduced noise and processing time for CT images to assess colon cancer. Aimed at primary care physicians in Brazil, Giavina-Bianchi et al. [[27]] demonstrated algorithms for melanoma screening using both dermascope and smart phone images (accuracy: 89%, 85%; sensitivity: 91%, 89%; specificity: 89%, 83%).

3.2 Radiology

Nine studies examined systems for a variety of clinical areas in hospital and outpatient radiology departments. Taking a theory driven approach, Rabinovich et al. [[28]] used the Technology Acceptance Model to evaluate user satisfaction and actual use of an assistive system for chest x-ray interpretation in an Argentinian emergency department (ED) over 5-months. The system was used for 15% of studies (n=1,186), with an average of eight accesses per day. Physicians and radiology residents had similar perceptions about system usability, but differed on output quality and usefulness.

Also using mixed-methods, Chonde et al. [[29]] studied the use and utility of an autonomous radiology examination instruction system called RadTranslate. The AI was integrated into imaging workflows for chest radiography at a COVID-19 triage outpatient centre that served a predominantly Spanish-speaking Latino community in the US. During the 63-day test period, technologists voluntarily switched to the system to provide instructions in Spanish. The system was found to reduce strain on medical interpreters and shortened examination length.

Two studies examined effects on decision-making and care delivery. Duron et al. [[30]] reported on the utility of AI to detect missed fractures in posttraumatic radiographs. 18 radiologists and emergency physicians were asked to detect and localise 600 fractures with and without AI highlighting of fractures. AI improved the sensitivity of physicians by 9% and the specificity by 4% and reduced the average number of false-positive fractures per patient by 42% and mean reading time by 15%. Schmuelling et al. [[31]] assessed the impact of a triage system that detected and alerted radiologists about ED cases with suspected pulmonary embolism on CT angiograms. While the study demonstrated good diagnostic accuracy (sensitivity 80%, specificity 95%, PPV 82%, and NPV 94%), there was no effect on report communication times and patient turnaround 9-months post-implementation.

Three studies examined assistive AI for chest x-ray and CT interpretation. Seah et al. [[32]] evaluated a comprehensive system that was trained to identify and highlight 127 radiological findings by asking 20 radiologists to review 2,568 cases with and without assistance in a controlled setting. The AI was shown to improve classification accuracy in 102 findings. Zhang et al. [[33]] investigated accuracy and efficiency in detecting rib fractures by asking radiologists to interpret CT images unassisted, assisted and with the AI as a second reader. AI as a second reader was found to improve detection accuracy (up to 6% more rib fractures) and reading efficiency (time reduced by 34-36%). Focussing on junior radiologists, Liu et al. [[34]] compared the diagnostic accuracy of an AI to identify rib fractures in chest CT images with and without assistance demonstrating improved sensitivity and reduced reading time by ~1 min per patient without decreasing the specificity.

Taking a qualitative approach, Lee et al. [[35]] describe their experiences in implementing an assistive AI for chest x-ray interpretation in a South Korean hospital. Both accuracy and immediate availability of results was reported to be critical, along with an explainable visualisation of results and the ability to configure software platforms for data presentation.

Focussing on trainees, Shiang et al. [[36]] surveyed 15 residents about their use of a commercial AI in a US residency curriculum. Here, residents were given access to an autonomous system that analysed CT images and notified clinicians about cases with suspected positive findings of pulmonary embolism, intracranial haemorrhage, and acute cervical spine fractures. Most residents (92%) supported incorporating AI into the curriculum and found it useful for triage (83%) and troubleshooting (67%), rather than for diagnostic purposes of speed (42%), accuracy (33%), or diagnosis determination (17%).

3.3 Triage

Six studies focussed on ED triage support. Hinson et al. [[37]] undertook a staged evaluation to assess an AI that provided a COVID-19 Clinical Deterioration Risk Level (1–10) in real-time based on EHR data. Prospective validation over 18-months at five EDs including an initial silent deployment demonstrated ML model performance for prediction of critical and inpatient care (AUC: 0.85–0.91; 0.80–0.90). Total mortality was reduced among high-risk patients.

Also focussing on COVID-19, Soltan et al. [[38]] evaluated a screening system in a United Kingdom ED. Automated identification using routinely collected data was reported to detect COVID-19 in 45 min, 61 min sooner than a lateral flow device, and 6 h 52 min (90%) sooner than PCR. Classification performance was high (sensitivity 87%; specificity 85%; and NPV 100%). The AI correctly excluded infection for 58% patients who were triaged by a physician to a COVID-19 suspected area but went on to test negative by PCR.

For chest pain, Wang et al. [[39]] demonstrated improved clinical decision-making and triage. Automated detection of ST-elevation myocardial infarction (STEMI) on electrocardiography (ECG) and clinical risk assessment (ASAP score) was reported to shorten the time to treatment (door-to-balloon time: 64 min to 53 min). Among patients with an ASAP score of 3 or higher, the median door-to-ECG time decreased (30 min to 6 min).

In a clinical simulation, Kim et al. [[40]] showed use of AI by ED clinicians for chest x-ray interpretation and decision-making improved their sensitivity to abnormalities regardless of experience (AUROC=0.801). Also focussed on decision-making, Ivanov et al. [[41]] demonstrated AI improved the accuracy of nursing triage in a US urban community hospital (paediatric: 54% to 67%; adult: 62% to 78%). Jordan et al.'s [[42]] qualitative examination of the impact of cultural embeddedness of this system found that although there was initial scepticism, the AI grew to be perceived as a safety net for triage decision-making among nurses.

3.4 Radiotherapy

Five studies examined autonomous and assistive AI for segmentation of organs at risk (OAR), treatment plans for breast cancer and risk assessment during therapy. Using mixed methods, Wong et al. [[43]] evaluated an AI-based auto-segmentation for central nervous system, head and neck, and prostate radiotherapy (RT) planning at two Canadian cancer centres. AI generated plans for 551 cases, required minimal edits and resulted in a positive user experience. Also using mixed-methods, Byun et al. [[44]] assessed an auto contouring system to delineate OAR for breast radiotherapy with an expert group. Performance of the AI was comparable with manual contouring by experts and was significantly faster (mean times for nine OAR: 37 min for manual vs. 6 min for corrected auto contours). The survey found good user satisfaction.

For prostate radiotherapy, Cha et al. [[45]] demonstrated clinical utility of AI for MR-based planning with 65% of cases requiring no more than minor edits, and a time saving of 12 min (30% of total contouring time) for physicians. Kneepkens et al. [[46]] found that although automatically generated plans resulted in slightly higher doses, they were clinically acceptable (AI: 90-95% vs. manual: 90%) and time-efficient.

Focussing on implementation, Hong et al. [[47]] examined the challenges with using EHR data to conduct an RCT of an AI to identify patients at high risk for ED visits and hospitalisation during cancer radiation therapy. They found data extraction and the need for manual review required significant time for implementing RCTs. Limited data availability through the standard clinical workflow and commercial products were seen to be a barrier.

3.5 Mental Health

Four studies examined AI for diagnosis and treatment of mental health conditions. Three mixed methods studies related to an AI that operationalised Canadian guidelines for depression treatment and provided clinicians with patient-specific remission probabilities for different treatment options [[48] [49] [50]]. Of these, two involved a high-fidelity clinical simulation with 20 staff or residents in psychiatry or family medicine completing three 10-min clinical interactions with standardised patients portraying mild, moderate, and severe episodes of major depressive disorder. In the first, Benrimoh et al. [[48]] focussed on ease of use and impact on physician-patient interaction. Clinicians indicated a willingness to use the tool in real clinical practice, placed a significant degree of trust in the system's predictions to assist with treatment selection, and its potential to increase patient understanding and trust. The second study focussed on utility; Tanguay-Sela et al. [[50]] reported 60% of physicians perceived the tool to be useful for treatment-selection, with family physicians perceiving the greatest utility. 50% indicated they would use the tool for all patients with depression, with an additional 35% noting that they would reserve the tool for more severe or treatment-resistant patients. The tool was also perceived to be useful in discussing treatment options with patients. Popescu et al. [[49]] assessed feasibility of using the tool during consultation by examining change in appointment length. Use of the tool over 11 months did not increase appointment length; most patients and physicians reported that the tool was easy to use and trustworthy but there were mixed perceptions about its impact on the patient-clinician relationship.

Focussing on suicide risk, Wilimitis et al. [[51]] evaluated automated detection in clinical settings by combining predictions from the Columbia Suicide Severity Rating Scale with a real-time ML model. Combined models outperformed the model alone for risks of suicide attempt and suicidal ideation in a cohort study of 120,398 adult patient encounters in the US.

3.6 Cardiovascular Disease

Three quantitative studies examined assistive and autonomous AI for diagnosis and procedures. Yao et al. [[52]] undertook a pragmatic RCT of an AI to detect and notify clinicians about patients with suspected findings of low left ventricular ejection fraction. The study involving 22,641 patients across diverse practice settings demonstrated an increased identification of low ejection fraction within 90 days of the ECG (control: 1.6% vs. intervention: 2.1%). Edalti et al. [[53]] evaluated two algorithms to improve image quality and reduce noise in MRI images showing automated acquisition reduced operator dependence and was 13% faster compared to manual planning of cardiac scans. Chen et al. [[54]] demonstrated potential of ECG interpretation assisted by a DL algorithm to improve diagnosis of cardiovascular events in patients with heart failure.

3.7 Dermatology

Three studies examined assistive and autonomous AI for diagnosis and monitoring. Pangti el al. [[55]] undertook a large-scale study involving 5,014 patients across a wide variety of clinical settings in India to demonstrate the utility of a smartphone mobile app as a point-of-care tool for diagnosis of 41 skin conditions in people of colour (accuracy: overall 75%; top 3: 90%). Jain et al. [[56]] demonstrated another AI to help clinicians diagnose skin conditions more accurately in US primary care practices. Here, 20 physicians and 20 nurse practitioners reviewed 1,048 cases with and without assistance of an AI system that provides a differential diagnosis from images of skin conditions and medical history. AI assistance was significantly associated with higher agreement with diagnoses made by a dermatologist panel, with an increase from 48% to 58% for physicians and 46% to 58% for nurse practitioners. For monitoring fine lines, Yoelin et al. [[57]] examined utilisation and functionality of an AI platform to automatically measure and score fine lines by asking 71 patients to use the system over 14 days. The AI was shown to evaluate photos on a comparable level of accuracy and was more consistent than qualified raters.

3.8 Diabetic Retinopathy

Three studies examined autonomous AI for diagnosis of diabetic retinopathy in different settings. Ipp et al. [[58]] undertook a multicentre cross-sectional diagnostic study including 942 individuals with diabetes to demonstrate safety and accuracy. The system accurately detected both more-than-mild diabetic retinopathy (mtmDR) and vision-threatening diabetic retinopathy (vtDR) without physician oversight or need for dilation in most individuals (mtmDR sensitivity: 96%, specificity: 88% and vtDR sensitivity: 97%, specificity: 90%). Hao et al.'s [[59]] evaluation involved 3,933 patients in a community hospital in rural China. The AI was demonstrated to have a sensitivity of 81% and specificity of 94% and was consistent with screening by ophthalmologists. Also in China, Ming et al. [[60]] examined feasibility of deploying AI in primary care. The system which was capable of both detecting and grading according to the International Clinical Diabetic Retinopathy scale was demonstrated to have high specificity (98%) and acceptable sensitivity (85%).

3.9 In-hospital Deterioration

Three US studies examined assistive AI for detection of in-hospital deterioration. Martinez et al. [[61]] described an early warning system that combined statistical modelling with ML to identify patients at risk of deterioration. Deployment across 19 hospitals was associated with decreases in mortality (10% vs. 14%), hospital length of stay, and intensive care unit length of stay. The study estimated that more than 500 deaths could be prevented each year by the intervention. Winslow et al.'s [[62]] deployment in medical-surgical wards across a multicentre health system over 10 months was associated with a decrease in hospital mortality (9% vs. 14%).

Focussing on sociotechnical dimensions, Schwartz et al.'s [[63]] application of the human-computer trust conceptual framework to explore clinician trust is particularly noteworthy. Here, nurses and prescribers from 24 acute and intensive care units in two hospitals were interviewed about their trust in the predictive AI. The study reported that trust was influenced by clinician perceptions about being able to form a mental model and predict future system behaviour as well as the system's technical capabilities to perform tasks accurately and correctly based on the information that is input. Trust was also influenced by actionability of system recommendations, scientific and anecdotal evidence as well as fairness in system predictions. The findings were largely similar between nurses and prescribers.

3.10 Stroke

The three studies of assistive and autonomous AI for stroke triage and diagnosis covered effects on decision-making, care delivery and patient outcomes. Gunda et al. [[64]] used mixed-methods to examine automated analysis of CT angiography at a primary stroke centre in Hungary. Use of AI over a 7-month period with 399 patients was reported to increase detection of thrombolysis (11%-18%) and thrombectomy (2.8%-4.8%). There was a trend towards shorter door-to-needle times (44–42 min) and CT-to-groin puncture times (174–145 min); and a non-significant trend towards improved outcomes with thrombectomy. Among physicians, the system was perceived to increase decision-making confidence and improved patient flow. Yahav-Dovrat et al. [[65]] evaluated the detection accuracy of an AI to detect large-vessel occlusions on CT angiograms and notify the treatment team in real-time via a dedicated mobile application at an Israeli stroke centre. The system was found to be highly accurate when used to scan all head and neck CT angiograms over a 15-month period. Hu et al.'s [[82]] examination of the safety and effectiveness of an AI to improve the quality of CT perfusion images reported improvements in image quality and thrombolytic therapy of acute cerebral infarct (14%).

3.11 Asthma, Sepsis, Venous Thromboembolism, Urinary Tract Infection

Four studies demonstrated effects of assistive AI on care delivery and/or patient outcomes in asthma, sepsis, and venous thromboembolism (VTE), as well as treatment of urinary tract infection. Seol et al. [[18]] conducted an RCT of an AI that provided a quarterly report to clinicians with relevant clinical information about asthma management along with a machine learned prediction for risk of exacerbation based on EHR data, patient-reported outcomes and non-clinical data (e.g. traffic volume and socioeconomic status). The study involving 184 patients in a US primary care paediatric practice found no difference in frequency of asthma exacerbations between the two groups (intervention: 12% vs. control: 15%), although the AI significantly reduced time for reviewing EHRs for asthma management (3 min vs. 11 min per patient). Another AI that leveraged the EHRs was evaluated by Adams et al. [[66]], here a real-time risk score was generated and used to alert clinicians about patients at risk of sepsis. A trial of this system at five hospitals was reported to reduce in-hospital mortality (treatment: 15% vs. comparison: 19%), organ failure and length of stay compared with patients whose alert was not confirmed by a provider within 3 hours. Taking a similar approach, Zhou et al. [[67]] evaluated an AI to identify and notify clinicians about patients at risk of VTE in hospital. AI-enabled automated assessment of VTE risk every 6 hours or upon EHR updates was found to reduce the rate of VTE during hospitalisation by 19% and increased anticoagulant drug use by 14%.

In primary care, Herter et al. [[68]] examined an AI that provided general practitioners with expected outcomes and support information about antibiotics for urinary tract infections based on the Dutch College of General Practitioners' guidelines. A prospective observational study in 36 primary care practices over a 4-month period was associated with an increase in proportion of successful treatments from 75% to 80% in intervention practices while there was no difference in the matched controls.

3.12 Hip Repair Surgery, Dental Care

Two studies examined effects of assistive AI on decision-making and user experience in hip repair surgery and dental care. Li et al. [[69]] evaluated an AI to assist anaesthesiologists in assessing the risk of complications in patients after a hip surgery. The system was demonstrated to outperform the American Society of Anesthesiologist-Physical Status (ASA-PS) score, the traditional risk stratification method. The online app was user-friendly and received high satisfaction scores from anaesthesiologists. Focussing on trainees, Glick et al. [[70]] evaluated the performance, efficiency, and confidence level of 41 dental students on radiographic identification of furcation involvement (bone loss at branching point of the root of teeth), with and without AI assistance. While the AI did not improve decision-making speed or confidence, both groups acknowledged the role of AI in improving clinical decisions. Students also tended to over rely on AI advice.

3.13 Iron-deficient Anaemia, Chronic Inflammatory Bowel Disease, COVID-19, Wound Care, Gastrointestinal Obstruction, Chronic Kidney Disease

Six studies examined effects of AI on decision-making in iron-deficient anaemia, chronic inflammatory bowel disease, COVID-19, wound care, gastrointestinal obstruction and chronic kidney disease. Kurstjens et al. [[71]] demonstrated the utility of an algorithm that automatically assessed the risk of low body iron storage based on age, sex, a routine blood count and C-reactive protein concentration. Implementation in a hospital laboratory system over a 1-month period resulted in one new iron deficiency diagnosis on average per day. Also using routinely collected data, Alrajhi et al. [[72]] demonstrated performance of a home-grown AI to predict the severity of COVID-19 infection for patients at hospital admission (recall: 78-90%; precision: 75-98%).

In imaging, Dong et al. [[73]] demonstrated utility of segmentation algorithm for CT images to evaluate the postoperative enteral nutrition and analyse the clinical treatment effect of high intestinal obstruction in neonates. The segmentation time of the algorithm was shorter than that of the traditional method (24 s vs. 75 s), and accuracy was higher (84% vs. 70%). Howell et al. [[74]] evaluated AI for wound assessment against manual assessments performed by wound care clinicians. While AI annotation algorithms performed similarly to human specialists, the degree of agreement regarding wound features among experts varied substantially, presenting challenges for defining a standard. Maeda et al. [[75]] undertook a prospective cohort study to show real-time use of AI during colonoscopy enabled prediction of the risk of clinical relapse in patients with ulcerative colitis in clinical remission. Chen et al. [[76]] demonstrated that an AI algorithm could improve image quality and reduce noise in CT images to assess nutritional management in chronic kidney disease.

3.14 Pneumonia and Sleep Disorders

Two studies reported processes to design assistive AI for triage of pneumonia and diagnosis of sleep disorders. Mohammed et al. [[17]] demonstrated the feasibility of using progressive web applications to migrate an ML-based pneumonia mortality prediction triage tool from an academic framework (paper and web-based prototype) to a mobile application for a resource-constrained context in Gambia. Hwang et al. [[77]] described their experience in using an iterative, user-centred design process with sleep technicians to develop clinically sound explanations for AI that automatically scores sleep studies.

4 Discussion

AI technologies are being applied in many clinical areas to improve patient care. Most contemporary systems are assistive and aimed at doctors in acute care settings in high-income nations. Studies provide evidence about AI systems being integrated and used with existing CISs including EHRs and supporting systems. Although most systems employ DL approaches, their algorithms are primarily trained on routinely collected data. Few utilised data about environmental and social factors, indicating limited support for the goals of One Health.

We found that 65% of systems were assistive, requiring users to confirm or approve AI provided information or decisions. This is consistent with the patterns observed in our analysis of ML-based medical devices approved by the US Food and Drug Administration where assistive devices made up 47% of the 49 reviewed [[15]]. Yet, little is known about the immediate and long-term effects of using such systems in clinical settings and is an area requiring further research [[78], [79]]. Immediate effects on users include the workload placed on clinicians to review and confirm AI output including the potential for errors [[80], [81]]. We found only one in five studies of assistive systems examined the effects on clinician time, and the two studies that assessed safety involved autonomous systems [[58], [82]]. The long-term effects on users include the loss of situational awareness and skill degradation which are well-documented effects of automation in other domains [[9]].

There is also a need to improve evaluation and reporting [[83], [84]]. Study designs were largely quantitative and aimed at examining effects on decision-making by comparing system performance against a gold standard (e.g., [[25], [56]]); or by comparing clinician performance with and without AI assistance (e.g., [[20], [21], [32]]). Few studies used randomised trial designs, opting instead for designs such as weaker historical case controls. Accuracy was most commonly measured, although a few studies examined safety and clinician time (e.g., [[44], [46], [53]]). Effects on care-delivery were assessed using a variety of measures including time to treatment (e.g., [[29], [39], [67], [68]]). Patient outcomes were assessed using measures like length of stay and mortality (e.g., [[61], [62], [66]]), but no studies examined adverse events due to AI errors. Though improvements in decision-making and care delivery are expected to improve patient outcomes, it cannot be assumed, making it essential to directly evaluate the effect of AI interventions on patient outcomes [[1], [16]].

While the current literature usefully provides evidence about beneficial effects on decision-making, care delivery and patient outcomes, little is known about the broader sociotechnical factors that affect the adoption and use of AI in routine settings. Few studies used mixed- or qualitative methods that can explain observed effects and examine the sociotechnical dimensions of AI [[85]]. There is also a need to improving report measures to identify and address ethical considerations for the use of AI in clinical settings [[84]].

Although a staged approach to implementation and evaluation was evident in many studies (e.g., [[48], [66]]), only three tracked actual use of systems by clinicians [[28], [29], [75]]. Evaluation of user experience was mostly confined to assessing satisfaction via surveys. A notable exception is the study by Rabinovich et al. [[28]] where the Technology Acceptance Model was employed to evaluate actual use and satisfaction post-implementation. Some studies used clinical simulation which permits patient- and risk-free evaluation and can inform real-world implementation [[21],[40],[48],[50]]. For instance, Benrimoh et al. [[48]] and Tanguay-Sela et al. [[50]] reported high fidelity clinical simulations that informed an 11-month study to examine use of an AI for mental health in primary care [[49]]. Clinical simulation is particularly valuable to measure effects on decision-making including automation bias and other potentially remediable human factors issue posing safety risks [[78]], that are not feasible or ethical to study in clinical settings. Importantly, it enables safety and efficacy to be assessed ahead of expensive clinical deployment [[86]].

Other studies reported strategies to incorporate well-known considerations for the use of digital health technologies such as ensuring that AI advice was actionable (e.g., when algorithms were designed to operationalise national guidelines [[48]]), and integrated into clinical workflow and existing CISs including EHRs (e.g., [[22], [29], [77]]). In one study where the AI was not integrated into the EHRs, general practitioners needed to enter patient characteristics into a web-based version of the AI [[68]]. A key challenge for system implementation is to build upon general considerations for digital health and identify specific measures required for the safe and effective use of ML algorithms. For instance, Schwartz et al. applied the human-computer trust conceptual framework to specifically examine trust around machine learned predictions of in-hospital deterioration [[63]]; Calisto et al. used the human-AI design guidelines to inform implementation of a breast screening AI into clinical workflow [[21]]. Another example is Jordan et al.'s study of the effects of cultural embeddedness on AI implementation in ED nursing triage [[42]].

Further work is also required to advance the goals of One Health via collaboration between the digital health and One Health communities [[87]]. Indeed, the One Health approach may help to move technology-driven AI beyond doctors in well-resourced acute care settings towards problem-driven systems addressing areas of specific clinical need and to improve equity in provision of health services [[88]]. Examples of such AI were evident in the studies we reviewed. For example, use of progressive web applications to migrate a pneumonia mortality prediction tool from a study prototype to a mobile app for a resource-constrained context was implemented in Gambia [[17]]. Another example is the use of non-clinical data such as traffic volume and socioeconomic status for predicting the risk of asthma exacerbations [[18]]. Other problem-driven examples include dermatology apps specifically developed for people of colour [[27], [55]], a radiology examination instruction system to support COVID-19 triage in a predominantly Spanish-speaking Latino community [[29]], and AI systems for trainee clinicians [[36], [70]].

5 Conclusions

This survey confirms that AI systems are being implemented and evaluated in many clinical areas. Most systems are assistive, requiring users to confirm or approve AI provided information or decisions. Study designs are largely quantitative measuring effects on decision-making, and there remain many opportunities to understand patterns of routine use and evaluate effects on care delivery and patient outcomes using mixed-methods. There is also a need to study the immediate and long-term effects of automation on human performance. No doubt newer generative AI that have potential to improve user interaction and reduce the burden associated with CISs need to be carefully evaluated as they come with their own risks that need to be managed. Support for One Health including better integration of data about environmental and social factors in CISs is another area for further exploration.

Die Autoren geben an, dass kein Interessenkonflikt besteht.

Acknowledgements

We thank Andre Nguyen and Ying Wang for their assistance with the searching and screening of articles.

Competing Interests

The authors have no competing interests to declare.

Contributions

FM conceptualised the study, undertook the literature search, performed data analysis and drafted the article. All authors participated in writing and revising the article. All aspects of the study (including design; collection, analysis, and interpretation of data; writing of the report; and decision to publish) were led by the authors.

• References

• 1 Coiera E. Guide to health informatics, third edition. CRC Press; 2015.
• 2 Coiera E. The fate of medicine in the time of AI. Lancet. 2018 Dec 1;392(10162):2331-2332. PubMed PMID: 30318263. Epub 2018/10/16. doi: 10.1016/s0140-6736(18)31925-1.
• 3 Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019 Jan;25(1):44-56. PubMed PMID: 30617339. Epub 2019/01/09. doi: 10.1038/s41591-018-0300-7.
• 4 One Health. Available from: https://www.who.int/news-room/questions-and-answers/item/one-health (last accessed: 10 Jan 2023).
• 5 Prata JC, Ribeiro AI, Rocha-Santos T. Chapter 1 - An introduction to the concept of One Health. In: Prata JC, Ribeiro AI, Rocha-Santos T, editors. One Health: Academic Press; 2022. p. 1-31. doi: 10.1016/B978-0-12-822794-7.00004-6
• 6 Dalton KR, Rock C, Carroll KC, Davis MF. One Health in hospitals: how understanding the dynamics of people, animals, and the hospital built-environment can be used to better inform interventions for antimicrobial-resistant gram-positive infections. Antimicrob Resist Infect Control. 2020 Jun 1;9(1):78. PubMed PMID: 32487220. Epub 2020/06/04. doi: 10.1186/s13756-020-00737-2.
• 7 Rahimi-Ardabili H, Magrabi F, Coiera E. Digital health for climate change mitigation and response: a scoping review. J Am Med Inform Assoc. 2022 Nov 14;29(12):2140-2152. PubMed PMID: 35960171. Epub 2022/08/13. doi: 10.1093/jamia/ocac134.
• 8 Domingos P. The Master Algorithm: How the Quest for the Ultimate Learning Machine Will Remake Our World: Penguin Books Limited; 2015.
• 9 Parasuraman R, Sheridan TB, Wickens CD. A model for types and levels of human interaction with automation. IEEE Trans Syst Man Cybern A Syst Hum. 2000 May;30(3):286-97. PubMed PMID: 11760769. Epub 2002/01/05. doi: 10.1109/3468.844354.
• 10 Coiera E, Liu S. Evidence synthesis, digital scribes, and translational challenges for artificial intelligence in healthcare. Cell Rep Med. 2022 Dec 20;3(12):100860. PubMed PMID: 36513071. Epub 2022/12/14. doi: 10.1016/j.xcrm.2022.100860.
• 11 Coiera E. The Last Mile: Where Artificial Intelligence Meets Reality. J Med Internet Res. 2019 Nov 8;21(11):e16323. PubMed PMID: 31702559. Epub 2019/11/09. doi: 10.2196/16323.
• 12 Challen R, Denny J, Pitt M, Gompels L, Edwards T, Tsaneva-Atanasova K. Artificial intelligence, bias and clinical safety. BMJ Qual Saf. 2019 Mar;28(3):231-237. PubMed PMID: 30636200. Epub 2019/01/14. doi: 10.1136/bmjqs-2018-008370.
• 13 Lyell D, Wang Y, Coiera E, Magrabi F. More than algorithms: an analysis of safety events involving ML-enabled medical devices reported to the FDA. J Am Med Inform Assoc. 2023 June 20;30(7):1227-1236. PubMed PMID: 37071804. Epub 2023/04/18. doi: 10.1093/jamia/ocad065.
• 14 United Nations. Country Classification: Data Sources, Country Classifications and Aggregation Methodology. New York (NY): United Nations; 2014: 143-150. Available from: https://www.un.org (last accessed: 10 Jan 2023).
• 15 Lyell D, Coiera E, Chen J, Shah P, Magrabi F. How machine learning is embedded to support clinician decision making: an analysis of FDA-approved medical devices. BMJ Health Care Inform. 2021 Apr;28(1):e100301. doi: 10.1136/bmjhci-2020-100301.
• 16 Coiera E. Assessing Technology Success and Failure Using Information Value Chain Theory. Stud Health Technol Inform. 2019 Jul 30;263:35-48. PubMed PMID: 31411151. Epub 2019/08/15. doi: 10.3233/shti190109.
• 17 Mohammed NI, Jarde A, Mackenzie G, D'Alessandro U, Jeffries D. Deploying Machine Learning Models Using Progressive Web Applications: Implementation Using a Neural Network Prediction Model for Pneumonia Related Child Mortality in The Gambia. Front Public Health. 2022;9:772620. PubMed PMID: 35252109. Epub 2022/03/08. doi: 10.3389/fpubh.2021.772620.
• 18 Seol HY, Shrestha P, Muth JF, Wi CI, Sohn S, Ryu E, et al. Artificial intelligence-assisted clinical decision support for childhood asthma management: A randomized clinical trial. PLoS One. 2021;16(8):e0255261. PubMed PMID: 34339438. Epub 2021/08/03. doi: 10.1371/journal.pone.0255261.
• 19 Wu L, He X, Liu M, Xie H, An P, Zhang J, et al. Evaluation of the effects of an artificial intelligence system on endoscopy quality and preliminary testing of its performance in detecting early gastric cancer: a randomized controlled trial. Endoscopy. 2021 Dec;53(12):1199-1207. PubMed PMID: 33429441. Epub 2021/01/12. doi: 10.1055/a-1350-5583.
• 20 Peng S, Liu Y, Lv W, Liu L, Zhou Q, Yang H, et al. Deep learning-based artificial intelligence model to assist thyroid nodule diagnosis and management: a multicentre diagnostic study. Lancet Digit Health. 2021 Apr;3(4):e250-e259. PubMed PMID: 33766289. Epub 2021/03/27. doi: 10.1016/s2589-7500(21)00041-8.
• 21 Calisto FM, Santiago C, Nunes N, Nascimento JC. BreastScreening-AI: Evaluating medical intelligent agents for human-AI interactions. Artif Intell Med. 2022 May;127:102285. PubMed PMID: 35430044. Epub 2022/04/18. doi: 10.1016/j.artmed.2022.102285.
• 22 Martins Jarnalo CO, Linsen PVM, Blazís SP, van der Valk PHM, Dickerscheid DBM. Clinical evaluation of a deep-learning-based computer-aided detection system for the detection of pulmonary nodules in a large teaching hospital. Clin Radiol. 2021 Nov;76(11):838-845. PubMed PMID: 34404517. Epub 2021/08/19. doi: 10.1016/j.crad.2021.07.012.
• 23 Quan SY, Wei MT, Lee J, Mohi-Ud-Din R, Mostaghim R, Sachdev R, et al. Clinical evaluation of a real-time artificial intelligence-based polyp detection system: a US multi-center pilot study. Sci Rep. 2022 Apr 21;12(1):6598. PubMed PMID: 35449442. Epub 2022/04/23. doi: 10.1038/s41598-022-10597-y.
• 24 Ou YC, Tsao TY, Chang MC, Lin YS, Yang WL, Hang JF, et al. Evaluation of an artificial intelligence algorithm for assisting the Paris System in reporting urinary cytology: A pilot study. Cancer Cytopathol. 2022 Nov;130(11):872-880. PubMed PMID: 35727052. Epub 2022/06/22. doi: 10.1002/cncy.22615.
• 25 Nasir-Moin M, Suriawinata AA, Ren B, Liu X, Robertson DJ, Bagchi S, et al. Evaluation of an Artificial Intelligence-Augmented Digital System for Histologic Classification of Colorectal Polyps. JAMA Netw Open. 2021 Nov 1;4(11):e2135271. PubMed PMID: 34792588. Epub 2021/11/19. doi: 10.1001/jamanetworkopen.2021.35271.
• 26 Duan X, Su D, Yu H, Xin W, Wang Y, Zhao Z. Adoption of Artificial Intelligence (AI)-Based Computerized Tomography (CT) Evaluation of Comprehensive Nursing in the Operation Room in Laparoscopy-Guided Radical Surgery of Colon Cancer. Comput Intell Neurosci. 2022;2022:2180788. PubMed PMID: 35300396. Epub 2022/03/19. doi: 10.1155/2022/2180788.
• 27 Giavina-Bianchi M, de Sousa RM, Paciello VZA, Vitor WG, Okita AL, Prôa R, et al. Implementation of artificial intelligence algorithms for melanoma screening in a primary care setting. PLoS One. 2021;16(9):e0257006. PubMed PMID: 34550970. Epub 2021/09/23. doi: 10.1371/journal.pone.0257006.
• 28 Rabinovich D, Mosquera C, Torrens P, Aineseder M, Benitez S. User Satisfaction with an AI System for Chest X-Ray Analysis Implemented in a Hospital's Emergency Setting. Stud Health Technol Inform. 2022 May 25;294:8-12. PubMed PMID: 35612006. Epub 2022/05/26. doi: 10.3233/shti220386.
• 29 Chonde DB, Pourvaziri A, Williams J, McGowan J, Moskos M, Alvarez C, et al. RadTranslate: An Artificial Intelligence-Powered Intervention for Urgent Imaging to Enhance Care Equity for Patients With Limited English Proficiency During the COVID-19 Pandemic. J Am Coll Radiol. 2021 Jul;18(7):1000-1008. PubMed PMID: 33609456. Epub 2021/02/21. doi: 10.1016/j.jacr.2021.01.013.
• 30 Duron L, Ducarouge A, Gillibert A, Lainé J, Allouche C, Cherel N, et al. Assessment of an AI Aid in Detection of Adult Appendicular Skeletal Fractures by Emergency Physicians and Radiologists: A Multicenter Cross-sectional Diagnostic Study. Radiology. 2021 Jul;300(1):120-129. PubMed PMID: 33944629. Epub 2021/05/05. doi: 10.1148/radiol.2021203886.
• 31 Schmuelling L, Franzeck FC, Nickel CH, Mansella G, Bingisser R, Schmidt N, et al. Deep learning-based automated detection of pulmonary embolism on CT pulmonary angiograms: No significant effects on report communication times and patient turnaround in the emergency department nine months after technical implementation. Eur J Radiol. 2021 Aug;141:109816. PubMed PMID: 34157638. Epub 2021/06/23. doi: 10.1016/j.ejrad.2021.109816.
• 32 Seah JCY, Tang CHM, Buchlak QD, Holt XG, Wardman JB, Aimoldin A, et al. Effect of a comprehensive deep-learning model on the accuracy of chest x-ray interpretation by radiologists: a retrospective, multireader multicase study. Lancet Digit Health. 2021 Aug;3(8):e496-e506. PubMed PMID: 34219054. Epub 2021/07/06. doi: 10.1016/s2589-7500(21)00106-0.
• 33 Zhang B, Jia C, Wu R, Lv B, Li B, Li F, et al. Improving rib fracture detection accuracy and reading efficiency with deep learning-based detection software: a clinical evaluation. Br J Radiol. 2021 Feb 1;94(1118):20200870. PubMed PMID: 33332979. Epub 2020/12/18. doi: 10.1259/bjr.20200870.
• 34 Liu X, Wu D, Xie H, Xu Y, Liu L, Tao X, et al. Clinical evaluation of AI software for rib fracture detection and its impact on junior radiologist performance. Acta Radiol. 2022 Nov;63(11):1535-1545. PubMed PMID: 34617809. Epub 2021/10/08. doi: 10.1177/02841851211043839.
• 35 Lee S, Shin HJ, Kim S, Kim EK. Successful Implementation of an Artificial Intelligence-Based Computer-Aided Detection System for Chest Radiography in Daily Clinical Practice. Korean J Radiol. 2022 Sep;23(9):847-852. PubMed PMID: 35762186. Epub 2022/06/29. doi: 10.3348/kjr.2022.0193.
• 36 Shiang T, Garwood E, Debenedectis CM. Artificial intelligence-based decision support system (AI-DSS) implementation in radiology residency: Introducing residents to AI in the clinical setting. Clin Imaging. 2022 Dec;92:32-7. PubMed PMID: 36183619. Epub 2022/10/03. doi: 10.1016/j.clinimag.2022.09.003.
• 37 Hinson JS, Klein E, Smith A, Toerper M, Dungarani T, Hager D, et al. Multisite implementation of a workflow-integrated machine learning system to optimize COVID-19 hospital admission decisions. NPJ Digit Med. 2022 Jul 16;5(1):94. PubMed PMID: 35842519. Epub 2022/07/17. doi: 10.1038/s41746-022-00646-1.
• 38 Soltan AAS, Yang J, Pattanshetty R, Novak A, Yang Y, Rohanian O, et al. Real-world evaluation of rapid and laboratory-free COVID-19 triage for emergency care: external validation and pilot deployment of artificial intelligence driven screening. Lancet Digit Health. 2022 Apr;4(4):e266-e278. PubMed PMID: 35279399. Epub 2022/03/14. doi: 10.1016/s2589-7500(21)00272-7.
• 39 Wang YC, Chen KW, Tsai BY, Wu MY, Hsieh PH, Wei JT, et al. Implementation of an All-Day Artificial Intelligence-Based Triage System to Accelerate Door-to-Balloon Times. Mayo Clin Proc. 2022 Dec;97(12):2291-303. PubMed PMID: 36336511. Epub 2022/11/07. doi: 10.1016/j.mayocp.2022.05.014.
• 40 Kim JH, Han SG, Cho A, Shin HJ, Baek S-E. Effect of deep learning-based assistive technology use on chest radiograph interpretation by emergency department physicians: a prospective interventional simulation-based study. BMC Med Inform Decis Mak. 2021 Nov 8;21(1):311. doi: 10.1186/s12911-021-01679-4.
• 41 Ivanov O, Wolf L, Brecher D, Lewis E, Masek K, Montgomery K, et al. Improving ED Emergency Severity Index Acuity Assignment Using Machine Learning and Clinical Natural Language Processing. J Emerg Nurs. 2021 Mar;47(2):265-278.e7. PubMed PMID: 33358394. Epub 2020/12/29. doi: 10.1016/j.jen.2020.11.001.
• 42 Jordan M, Hauser J, Cota S, Li H, Wolf L. The Impact of Cultural Embeddedness on the Implementation of an Artificial Intelligence Program at Triage: A Qualitative Study. J Transcult Nurs. 2023 Jan;34(1):32-39. PubMed PMID: 36214065. Epub 2022/10/11. doi: 10.1177/10436596221129226.
• 43 Wong J, Huang V, Wells D, Giambattista J, Giambattista J, Kolbeck C, et al. Implementation of deep learning-based auto-segmentation for radiotherapy planning structures: a workflow study at two cancer centers. Radiat Oncol. 2021 Jun 8;16(1):101. PubMed PMID: 34103062. Epub 2021/06/10. doi: 10.1186/s13014-021-01831-4.
• 44 Byun HK, Chang JS, Choi MS, Chun J, Jung J, Jeong C, et al. Evaluation of deep learning-based autosegmentation in breast cancer radiotherapy. Radiat Oncol. 2021 Oct 14;16(1):203. PubMed PMID: 34649569. Epub 2021/10/16. doi: 10.1186/s13014-021-01923-1.
• 45 Cha E, Elguindi S, Onochie I, Gorovets D, Deasy JO, Zelefsky M, et al. Clinical implementation of deep learning contour autosegmentation for prostate radiotherapy. Radiother Oncol. 2021 Jun;159:1-7. PubMed PMID: 33667591. Epub 2021/03/06. doi: 10.1016/j.radonc.2021.02.040.
• 46 Kneepkens E, Bakx N, van der Sangen M, Theuws J, van der Toorn PP, Rijkaart D, et al. Clinical evaluation of two AI models for automated breast cancer plan generation. Radiat Oncol. 2022 Feb 5;17(1):25. PubMed PMID: 35123517. Epub 2022/02/07. doi: 10.1186/s13014-022-01993-9.
• 47 Hong JC, Eclov NCW, Stephens SJ, Mowery YM, Palta M. Implementation of machine learning in the clinic: challenges and lessons in prospective deployment from the System for High Intensity EvaLuation During Radiation Therapy (SHIELD-RT) randomized controlled study. BMC Bioinformatics. 2022 Sep 30;23(Suppl 12):408. PubMed PMID: 36180836. Epub 2022/10/01. doi: 10.1186/s12859-022-04940-3.
• 48 Benrimoh D, Tanguay-Sela M, Perlman K, Israel S, Mehltretter J, Armstrong C, et al. Using a simulation centre to evaluate preliminary acceptability and impact of an artificial intelligence-powered clinical decision support system for depression treatment on the physician-patient interaction. BJPsych Open. 2021 Jan 6;7(1):e22. PubMed PMID: 33403948. Epub 20210106. doi: 10.1192/bjo.2020.127.
• 49 Popescu C, Golden G, Benrimoh D, Tanguay-Sela M, Slowey D, Lundrigan E, et al. Evaluating the Clinical Feasibility of an Artificial Intelligence-Powered, Web-Based Clinical Decision Support System for the Treatment of Depression in Adults: Longitudinal Feasibility Study. JMIR Form Res. 2021 Oct 25;5(10):e31862. PubMed PMID: 34694234. Epub 20211025. doi: 10.2196/31862.
• 50 Tanguay-Sela M, Benrimoh D, Popescu C, Perez T, Rollins C, Snook E, et al. Evaluating the perceived utility of an artificial intelligence-powered clinical decision support system for depression treatment using a simulation center. Psychiatry Res. 2022 Feb;308:114336. PubMed PMID: 34953204. Epub 2021/12/26. doi: 10.1016/j.psychres.2021.114336.
• 51 Wilimitis D, Turer RW, Ripperger M, McCoy AB, Sperry SH, Fielstein EM, et al. Integration of Face-to-Face Screening With Real-time Machine Learning to Predict Risk of Suicide Among Adults. JAMA Netw Open. 2022 May 2;5(5):e2212095. PubMed PMID: 35560048. Epub 2022/05/14. doi: 10.1001/jamanetworkopen.2022.12095.
• 52 Yao X, Rushlow DR, Inselman JW, McCoy RG, Thacher TD, Behnken EM, et al. Artificial intelligence-enabled electrocardiograms for identification of patients with low ejection fraction: a pragmatic, randomized clinical trial. Nat Med. 2021 May;27(5):815-9. PubMed PMID: 33958795. Epub 20210506. doi: 10.1038/s41591-021-01335-4.
• 53 Edalati M, Zheng Y, Watkins MP, Chen J, Liu L, Zhang S, et al. Implementation and prospective clinical validation of AI-based planning and shimming techniques in cardiac MRI. Med Phys. 2022 Jan;49(1):129-143. PubMed PMID: 34748660. Epub 2021/11/09. doi: 10.1002/mp.15327.
• 54 Chen J, Gao Y. The Role of Deep Learning-Based Echocardiography in the Diagnosis and Evaluation of the Effects of Routine Anti-Heart-Failure Western Medicines in Elderly Patients with Acute Left Heart Failure. J Healthc Eng. 2021;2021:4845792. PubMed PMID: 34422243. Epub 2021/08/24. doi: 10.1155/2021/4845792.
• 55 Pangti R, Mathur J, Chouhan V, Kumar S, Rajput L, Shah S, et al. A machine learning-based, decision support, mobile phone application for diagnosis of common dermatological diseases. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):536-45. PubMed PMID: 32991767. Epub 2020/09/30. doi: 10.1111/jdv.16967.
• 56 Jain A, Way D, Gupta V, Gao Y, de Oliveira Marinho G, Hartford J, et al. Development and Assessment of an Artificial Intelligence-Based Tool for Skin Condition Diagnosis by Primary Care Physicians and Nurse Practitioners in Teledermatology Practices. JAMA Netw Open. 2021 Apr 1;4(4):e217249. PubMed PMID: 33909055. Epub 2021/04/29. doi: 10.1001/jamanetworkopen.2021.7249.
• 57 Yoelin S, Green JB, Dhawan SS, Hasan F, Mahbod B, Khan B, et al. The Use of a Novel Artificial Intelligence Platform for the Evaluation of Rhytids. Aesthet Surg J. 2022 Oct 13;42(11):NP688-NP694. PubMed PMID: 35869540. Epub 2022/07/23. doi: 10.1093/asj/sjac200.
• 58 Ipp E, Liljenquist D, Bode B, Shah VN, Silverstein S, Regillo CD, et al. Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy. JAMA Netw Open. 2021 Nov 1;4(11):e2134254. PubMed PMID: 34779843. Epub 2021/11/16. doi: 10.1001/jamanetworkopen.2021.34254.
• 59 Hao S, Liu C, Li N, Wu Y, Li D, Gao Q, et al. Clinical evaluation of AI-assisted screening for diabetic retinopathy in rural areas of midwest China. PLoS One. 2022;17(10):e0275983. PubMed PMID: 36227905. Epub 2022/10/14. doi: 10.1371/journal.pone.0275983.
• 60 Ming S, Xie K, Lei X, Yang Y, Zhao Z, Li S, et al. Evaluation of a novel artificial intelligence-based screening system for diabetic retinopathy in community of China: a real-world study. Int Ophthalmol. 2021 Apr;41(4):1291-1299. PubMed PMID: 33389425. Epub 2021/01/04. doi: 10.1007/s10792-020-01685-x.
• 61 Martinez VA, Betts RK, Scruth EA, Buckley JD, Cadiz VR, Bertrand LD, et al. The Kaiser Permanente Northern California Advance Alert Monitor Program: An Automated Early Warning System for Adults at Risk for In-Hospital Clinical Deterioration. Jt Comm J Qual Patient Saf. 2022 Aug;48(8):370-375. PubMed PMID: 35902140. Epub 2022/07/29. doi: 10.1016/j.jcjq.2022.05.005.
• 62 Winslow CJ, Edelson DP, Churpek MM, Taneja M, Shah NS, Datta A, et al. The Impact of a Machine Learning Early Warning Score on Hospital Mortality: A Multicenter Clinical Intervention Trial. Crit Care Med. 2022 Sep 1;50(9):1339-1347. PubMed PMID: 35452010. Epub 2022/04/23. doi: 10.1097/ccm.0000000000005492.
• 63 Schwartz JM, George M, Rossetti SC, Dykes PC, Minshall SR, Lucas E, et al. Factors Influencing Clinician Trust in Predictive Clinical Decision Support Systems for In-Hospital Deterioration: Qualitative Descriptive Study. JMIR Hum Factors. 2022 May 12;9(2):e33960. PubMed PMID: 35550304. Epub 20220512. doi: 10.2196/33960.
• 64 Gunda B, Neuhaus A, Sipos I, Stang R, Böjti PP, Takács T, et al. Improved Stroke Care in a Primary Stroke Centre Using AI-Decision Support. Cerebrovasc Dis Extra. 2022;12(1):28-32. PubMed PMID: 35134802. Epub 20220208. doi: 10.1159/000522423.
• 65 Yahav-Dovrat A, Saban M, Merhav G, Lankri I, Abergel E, Eran A, et al. Evaluation of Artificial Intelligence-Powered Identification of Large-Vessel Occlusions in a Comprehensive Stroke Center. AJNR Am J Neuroradiol. 2021 Jan;42(2):247-254. PubMed PMID: 33384294. Epub 2021/01/02. doi: 10.3174/ajnr.A6923.
• 66 Adams R, Henry KE, Sridharan A, Soleimani H, Zhan A, Rawat N, et al. Prospective, multi-site study of patient outcomes after implementation of the TREWS machine learning-based early warning system for sepsis. Nat Med. 2022 Jul;28(7):1455-1460. PubMed PMID: 35864252. Epub 2022/07/22. doi: 10.1038/s41591-022-01894-0.
• 67 Zhou S, Ma X, Jiang S, Huang X, You Y, Shang H, et al. A retrospective study on the effectiveness of Artificial Intelligence-based Clinical Decision Support System (AI-CDSS) to improve the incidence of hospital-related venous thromboembolism (VTE). Ann Transl Med. 2021 Mar;9(6):491. PubMed PMID: 33850888. Epub 2021/04/15. doi: 10.21037/atm-21-1093.
• 68 Herter WE, Khuc J, Cinà G, Knottnerus BJ, Numans ME, Wiewel MA, et al. Impact of a Machine Learning-Based Decision Support System for Urinary Tract Infections: Prospective Observational Study in 36 Primary Care Practices. JMIR Med Inform. 2022 May 4;10(5):e27795. PubMed PMID: 35507396. Epub 2022/05/05. doi: 10.2196/27795.
• 69 Li YY, Wang JJ, Huang SH, Kuo CL, Chen JY, Liu CF, et al. Implementation of a machine learning application in preoperative risk assessment for hip repair surgery. BMC Anesthesiol. 2022 Apr 23;22(1):116. PubMed PMID: 35459103. Epub 2022/04/24. doi: 10.1186/s12871-022-01648-y.
• 70 Glick A, Clayton M, Angelov N, Chang J. Impact of explainable artificial intelligence assistance on clinical decision-making of novice dental clinicians. JAMIA Open. 2022 Jul;5(2):ooac031. PubMed PMID: 35651525. Epub 2022/06/03. doi: 10.1093/jamiaopen/ooac031.
• 71 Kurstjens S, de Bel T, van der Horst A, Kusters R, Krabbe J, van Balveren J. Automated prediction of low ferritin concentrations using a machine learning algorithm. Clin Chem Lab Med. 2022 Nov 25;60(12):1921-1928. PubMed PMID: 35258239. Epub 2022/03/09. doi: 10.1515/cclm-2021-1194.
• 72 Alrajhi AA, Alswailem OA, Wali G, Alnafee K, AlGhamdi S, Alarifi J, et al. Data-Driven Prediction for COVID-19 Severity in Hospitalized Patients. Int J Environ Res Public Health. 2022 Mar 3;19(5):2958. PubMed PMID: 35270653. Epub 2022/03/11. doi: 10.3390/ijerph19052958.
• 73 Dong Y, Wang Z, Zhang Z, Niu B, Chen P, Zhang P, et al. Artificial Intelligence Algorithm-Based Computed Tomography Images in the Evaluation of the Curative Effect of Enteral Nutrition after Neonatal High Intestinal Obstruction Operation. J Healthc Eng. 2021;2021:7096286. PubMed PMID: 34824765. Epub 2021/11/27. doi: 10.1155/2021/7096286.
• 74 Howell RS, Liu HH, Khan AA, Woods JS, Lin LJ, Saxena M, et al. Development of a Method for Clinical Evaluation of Artificial Intelligence-Based Digital Wound Assessment Tools. JAMA Netw Open. 2021 May 3;4(5):e217234. PubMed PMID: 34009348. Epub 2021/05/20. doi: 10.1001/jamanetworkopen.2021.7234.
• 75 Maeda Y, Kudo SE, Ogata N, Misawa M, Iacucci M, Homma M, et al. Evaluation in real-time use of artificial intelligence during colonoscopy to predict relapse of ulcerative colitis: a prospective study. Gastrointest Endosc. 2022 Apr;95(4):747-756.e2. PubMed PMID: 34695422. Epub 2021/10/26. doi: 10.1016/j.gie.2021.10.019.
• 76 Chen X, Huang X, Yin M. Implementation of Hospital-to-Home Model for Nutritional Nursing Management of Patients with Chronic Kidney Disease Using Artificial Intelligence Algorithm Combined with CT Internet. Contrast Media Mol Imaging. 2022;2022:1183988. PubMed PMID: 35414801. Epub 2022/04/14. doi: 10.1155/2022/1183988.
• 77 Hwang J, Lee T, Lee H, Byun S. A Clinical Decision Support System for Sleep Staging Tasks With Explanations From Artificial Intelligence: User-Centered Design and Evaluation Study. J Med Internet Res. 2022 Jan 19;24(1):e28659. PubMed PMID: 35044311. Epub 2022/01/20. doi: 10.2196/28659.
• 78 Sujan M, Furniss D, Grundy K, Grundy H, Nelson D, Elliott M, et al. Human factors challenges for the safe use of artificial intelligence in patient care. BMJ Health Care Inform. 2019 Nov;26(1):e100081. PubMed PMID: 31780459. Epub 2019/11/30. doi: 10.1136/bmjhci-2019-100081.
• 79 Sujan M, Pool R, Salmon P. Eight human factors and ergonomics principles for healthcare artificial intelligence. BMJ Health Care Inform. 2022 Feb;29(1):e100516. PubMed PMID: 35121617. Epub 2022/02/06. doi: 10.1136/bmjhci-2021-100516.
• 80 Kim MO, Coiera E, Magrabi F. Problems with health information technology and their effects on care delivery and patient outcomes: a systematic review. J Am Med Inform Assoc. 2017 Mar 01;24(2):246-250. PubMed PMID: 28011595. Epub 2016/12/25. doi: 10.1093/jamia/ocw154.
• 81 Lyell D, Coiera E. Automation bias and verification complexity: a systematic review. J Am Med Inform Assoc. 2017 Mar 1;24(2):423-431. PubMed PMID: 27516495. Epub 2016/08/16. doi: 10.1093/jamia/ocw105.
• 82 Hu M, Chen N, Zhou X, Wu Y, Ma C. Deep Learning-Based Computed Tomography Perfusion Imaging to Evaluate the Effectiveness and Safety of Thrombolytic Therapy for Cerebral Infarct with Unknown Time of Onset. Contrast Media Mol Imaging. 2022;2022:9684584. PubMed PMID: 35615733. Epub 2022/05/27. doi: 10.1155/2022/9684584.
• 83 Magrabi F, Ammenwerth E, McNair JB, De Keizer NF, Hypponen H, Nykanen P, et al. Artificial Intelligence in Clinical Decision Support: Challenges for Evaluating AI and Practical Implications. Yearb Med Inform. 2019 Aug;28(1):128-134. PubMed PMID: 31022752. Epub 2019/04/26. doi: 10.1055/s-0039-1677903.
• 84 Vasey B, Nagendran M, Campbell B, Clifton DA, Collins GS, Denaxas S, et al. Reporting guideline for the early stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI. BMJ. 2022 May 18;377:e070904. PubMed PMID: 35584845. Epub 2022/05/19. doi: 10.1136/bmj-2022-070904.
• 85 Sittig DF, Singh H. A new sociotechnical model for studying health information technology in complex adaptive healthcare systems. Qual Saf Health Care. 2010 Oct;19 Suppl 3(Suppl 3):i68-74. PubMed PMID: 20959322. Epub 2010/10/27. doi: 10.1136/qshc.2010.042085.
• 86 Lyell D, Lustig A, Denyer K, Vedantam S, Magrabi F. Using clinical simulation to evaluate AI-enabled decision support. In proceedings of Medinfo - the19th World Congress on Medical and Health Informatics (8 -12 July, Sydney) 2023. (to appear).
• 87 Benis A, Tamburis O, Chronaki C, Moen A. One Digital Health: A Unified Framework for Future Health Ecosystems. J Med Internet Res. 2021 Feb 5;23(2):e22189. PubMed PMID: 33492240. Epub 2021/01/26. doi: 10.2196/22189.
• 88 Celi LA, Cellini J, Charpignon M-L, Dee EC, Dernoncourt F, Eber R, et al. Sources of bias in artificial intelligence that perpetuate healthcare disparities—A global review. PLOS Digit Health. 2022;1(3):e0000022. doi: 10.1371/journal.pdig.0000022.

Publikationsverlauf

Artikel online veröffentlicht:
26. Dezember 2023